English
简体中文
Total: £ 56.28
Published Date: 2026-03-18 | Pages: 138 | Tables: 136 | Medical Care
The global Infusion Therapies and Technology market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Infusion Therapies and Technology is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Infusion Therapies and Technology is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Infusion Therapies and Technology in Basic Infusion is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Infusion Therapies and Technology include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, ICU Medical, SSY Group, Shuang Hor, Cisen Pharmaceutical, PiSA Farmacéutica, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Infusion Therapies and Technology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infusion Therapies and Technology. The Infusion Therapies and Technology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Infusion Therapies and Technology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infusion Therapies and Technology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Baxter Healthcare
Kelun Group
Fresenius
B. Braun
Ostuka Pharmaceutical
ICU Medical
SSY Group
Shuang Hor
Cisen Pharmaceutical
PiSA Farmacéutica
Huaren Pharmaceutical
Chimin
Beximco Pharma
Albert David
PSI Ltd
Ozon Pharmaceuticals
BML Parenteral Drugs
Segment by Type
Large Volume Intravenous Infusion
Small Volume Intravenous Infusion
Segment by Application
Basic Infusion
Therapeutic Infusion
Nutritious Infusion
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Infusion Therapies and Technology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infusion Therapies and Technology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Large Volume Intravenous Infusion
1.2.3 Small Volume Intravenous Infusion
1.3 Market by Application
1.3.1 Global Infusion Therapies and Technology Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infusion Therapies and Technology Market Perspective (2021–2032)
2.2 Global Infusion Therapies and Technology Growth Trends by Region
2.2.1 Global Infusion Therapies and Technology Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Infusion Therapies and Technology Historic Market Size by Region (2021–2026)
2.2.3 Infusion Therapies and Technology Forecasted Market Size by Region (2027–2032)
2.3 Infusion Therapies and Technology Market Dynamics
2.3.1 Infusion Therapies and Technology Industry Trends
2.3.2 Infusion Therapies and Technology Market Drivers
2.3.3 Infusion Therapies and Technology Market Challenges
2.3.4 Infusion Therapies and Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infusion Therapies and Technology Players by Revenue
3.1.1 Global Top Infusion Therapies and Technology Players by Revenue (2021–2026)
3.1.2 Global Infusion Therapies and Technology Revenue Market Share by Players (2021–2026)
3.2 Global Top Infusion Therapies and Technology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Infusion Therapies and Technology Revenue
3.4 Global Infusion Therapies and Technology Market Concentration Ratio
3.4.1 Global Infusion Therapies and Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infusion Therapies and Technology Revenue in 2025
3.5 Global Key Players of Infusion Therapies and Technology Head Offices and Areas Served
3.6 Global Key Players of Infusion Therapies and Technology, Products and Applications
3.7 Global Key Players of Infusion Therapies and Technology, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Infusion Therapies and Technology Breakdown Data by Type
4.1 Global Infusion Therapies and Technology Historic Market Size by Type (2021–2026)
4.2 Global Infusion Therapies and Technology Forecasted Market Size by Type (2027–2032)
5 Infusion Therapies and Technology Breakdown Data by Application
5.1 Global Infusion Therapies and Technology Historic Market Size by Application (2021–2026)
5.2 Global Infusion Therapies and Technology Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Infusion Therapies and Technology Market Size (2021–2032)
6.2 North America Infusion Therapies and Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Infusion Therapies and Technology Market Size by Country (2021–2026)
6.4 North America Infusion Therapies and Technology Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infusion Therapies and Technology Market Size (2021–2032)
7.2 Europe Infusion Therapies and Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Infusion Therapies and Technology Market Size by Country (2021–2026)
7.4 Europe Infusion Therapies and Technology Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Infusion Therapies and Technology Market Size (2021–2032)
8.2 Asia-Pacific Infusion Therapies and Technology Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Infusion Therapies and Technology Market Size by Region (2021–2026)
8.4 Asia-Pacific Infusion Therapies and Technology Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Infusion Therapies and Technology Market Size (2021–2032)
9.2 Latin America Infusion Therapies and Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Infusion Therapies and Technology Market Size by Country (2021–2026)
9.4 Latin America Infusion Therapies and Technology Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infusion Therapies and Technology Market Size (2021–2032)
10.2 Middle East & Africa Infusion Therapies and Technology Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Infusion Therapies and Technology Market Size by Country (2021–2026)
10.4 Middle East & Africa Infusion Therapies and Technology Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter Healthcare
11.1.1 Baxter Healthcare Company Details
11.1.2 Baxter Healthcare Business Overview
11.1.3 Baxter Healthcare Infusion Therapies and Technology Introduction
11.1.4 Baxter Healthcare Revenue in Infusion Therapies and Technology Business (2021–2026)
11.1.5 Baxter Healthcare Recent Development
11.2 Kelun Group
11.2.1 Kelun Group Company Details
11.2.2 Kelun Group Business Overview
11.2.3 Kelun Group Infusion Therapies and Technology Introduction
11.2.4 Kelun Group Revenue in Infusion Therapies and Technology Business (2021–2026)
11.2.5 Kelun Group Recent Development
11.3 Fresenius
11.3.1 Fresenius Company Details
11.3.2 Fresenius Business Overview
11.3.3 Fresenius Infusion Therapies and Technology Introduction
11.3.4 Fresenius Revenue in Infusion Therapies and Technology Business (2021–2026)
11.3.5 Fresenius Recent Development
11.4 B. Braun
11.4.1 B. Braun Company Details
11.4.2 B. Braun Business Overview
11.4.3 B. Braun Infusion Therapies and Technology Introduction
11.4.4 B. Braun Revenue in Infusion Therapies and Technology Business (2021–2026)
11.4.5 B. Braun Recent Development
11.5 Ostuka Pharmaceutical
11.5.1 Ostuka Pharmaceutical Company Details
11.5.2 Ostuka Pharmaceutical Business Overview
11.5.3 Ostuka Pharmaceutical Infusion Therapies and Technology Introduction
11.5.4 Ostuka Pharmaceutical Revenue in Infusion Therapies and Technology Business (2021–2026)
11.5.5 Ostuka Pharmaceutical Recent Development
11.6 ICU Medical
11.6.1 ICU Medical Company Details
11.6.2 ICU Medical Business Overview
11.6.3 ICU Medical Infusion Therapies and Technology Introduction
11.6.4 ICU Medical Revenue in Infusion Therapies and Technology Business (2021–2026)
11.6.5 ICU Medical Recent Development
11.7 SSY Group
11.7.1 SSY Group Company Details
11.7.2 SSY Group Business Overview
11.7.3 SSY Group Infusion Therapies and Technology Introduction
11.7.4 SSY Group Revenue in Infusion Therapies and Technology Business (2021–2026)
11.7.5 SSY Group Recent Development
11.8 Shuang Hor
11.8.1 Shuang Hor Company Details
11.8.2 Shuang Hor Business Overview
11.8.3 Shuang Hor Infusion Therapies and Technology Introduction
11.8.4 Shuang Hor Revenue in Infusion Therapies and Technology Business (2021–2026)
11.8.5 Shuang Hor Recent Development
11.9 Cisen Pharmaceutical
11.9.1 Cisen Pharmaceutical Company Details
11.9.2 Cisen Pharmaceutical Business Overview
11.9.3 Cisen Pharmaceutical Infusion Therapies and Technology Introduction
11.9.4 Cisen Pharmaceutical Revenue in Infusion Therapies and Technology Business (2021–2026)
11.9.5 Cisen Pharmaceutical Recent Development
11.10 PiSA Farmacéutica
11.10.1 PiSA Farmacéutica Company Details
11.10.2 PiSA Farmacéutica Business Overview
11.10.3 PiSA Farmacéutica Infusion Therapies and Technology Introduction
11.10.4 PiSA Farmacéutica Revenue in Infusion Therapies and Technology Business (2021–2026)
11.10.5 PiSA Farmacéutica Recent Development
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Company Details
11.11.2 Huaren Pharmaceutical Business Overview
11.11.3 Huaren Pharmaceutical Infusion Therapies and Technology Introduction
11.11.4 Huaren Pharmaceutical Revenue in Infusion Therapies and Technology Business (2021–2026)
11.11.5 Huaren Pharmaceutical Recent Development
11.12 Chimin
11.12.1 Chimin Company Details
11.12.2 Chimin Business Overview
11.12.3 Chimin Infusion Therapies and Technology Introduction
11.12.4 Chimin Revenue in Infusion Therapies and Technology Business (2021–2026)
11.12.5 Chimin Recent Development
11.13 Beximco Pharma
11.13.1 Beximco Pharma Company Details
11.13.2 Beximco Pharma Business Overview
11.13.3 Beximco Pharma Infusion Therapies and Technology Introduction
11.13.4 Beximco Pharma Revenue in Infusion Therapies and Technology Business (2021–2026)
11.13.5 Beximco Pharma Recent Development
11.14 Albert David
11.14.1 Albert David Company Details
11.14.2 Albert David Business Overview
11.14.3 Albert David Infusion Therapies and Technology Introduction
11.14.4 Albert David Revenue in Infusion Therapies and Technology Business (2021–2026)
11.14.5 Albert David Recent Development
11.15 PSI Ltd
11.15.1 PSI Ltd Company Details
11.15.2 PSI Ltd Business Overview
11.15.3 PSI Ltd Infusion Therapies and Technology Introduction
11.15.4 PSI Ltd Revenue in Infusion Therapies and Technology Business (2021–2026)
11.15.5 PSI Ltd Recent Development
11.16 Ozon Pharmaceuticals
11.16.1 Ozon Pharmaceuticals Company Details
11.16.2 Ozon Pharmaceuticals Business Overview
11.16.3 Ozon Pharmaceuticals Infusion Therapies and Technology Introduction
11.16.4 Ozon Pharmaceuticals Revenue in Infusion Therapies and Technology Business (2021–2026)
11.16.5 Ozon Pharmaceuticals Recent Development
11.17 BML Parenteral Drugs
11.17.1 BML Parenteral Drugs Company Details
11.17.2 BML Parenteral Drugs Business Overview
11.17.3 BML Parenteral Drugs Infusion Therapies and Technology Introduction
11.17.4 BML Parenteral Drugs Revenue in Infusion Therapies and Technology Business (2021–2026)
11.17.5 BML Parenteral Drugs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Infusion Therapies and Technology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Large Volume Intravenous Infusion
Table 3. Key Players of Small Volume Intravenous Infusion
Table 4. Global Infusion Therapies and Technology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Infusion Therapies and Technology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Infusion Therapies and Technology Market Size by Region (US$ Million), 2021–2026
Table 7. Global Infusion Therapies and Technology Market Share by Region (2021–2026)
Table 8. Global Infusion Therapies and Technology Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Infusion Therapies and Technology Market Share by Region (2027–2032)
Table 10. Infusion Therapies and Technology Market Trends
Table 11. Infusion Therapies and Technology Market Drivers
Table 12. Infusion Therapies and Technology Market Challenges
Table 13. Infusion Therapies and Technology Market Restraints
Table 14. Global Infusion Therapies and Technology Revenue by Players (US$ Million), 2021–2026
Table 15. Global Infusion Therapies and Technology Market Share by Players (2021–2026)
Table 16. Global Top Infusion Therapies and Technology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Infusion Therapies and Technology Revenue, 2025
Table 17. Ranking of Global Top Infusion Therapies and Technology Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Infusion Therapies and Technology Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Infusion Therapies and Technology, Headquarters and Area Served
Table 20. Global Key Players of Infusion Therapies and Technology, Products and Applications
Table 21. Global Key Players of Infusion Therapies and Technology, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Infusion Therapies and Technology Market Size by Type (US$ Million), 2021–2026
Table 24. Global Infusion Therapies and Technology Revenue Market Share by Type (2021–2026)
Table 25. Global Infusion Therapies and Technology Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Infusion Therapies and Technology Revenue Market Share by Type (2027–2032)
Table 27. Global Infusion Therapies and Technology Market Size by Application (US$ Million), 2021–2026
Table 28. Global Infusion Therapies and Technology Revenue Market Share by Application (2021–2026)
Table 29. Global Infusion Therapies and Technology Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Infusion Therapies and Technology Revenue Market Share by Application (2027–2032)
Table 31. North America Infusion Therapies and Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Infusion Therapies and Technology Market Size by Country (US$ Million), 2021–2026
Table 33. North America Infusion Therapies and Technology Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Infusion Therapies and Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Infusion Therapies and Technology Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Infusion Therapies and Technology Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Infusion Therapies and Technology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Infusion Therapies and Technology Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Infusion Therapies and Technology Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Infusion Therapies and Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Infusion Therapies and Technology Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Infusion Therapies and Technology Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Infusion Therapies and Technology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Infusion Therapies and Technology Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Infusion Therapies and Technology Market Size by Country (US$ Million), 2027–2032
Table 46. Baxter Healthcare Company Details
Table 47. Baxter Healthcare Business Overview
Table 48. Baxter Healthcare Infusion Therapies and Technology Product
Table 49. Baxter Healthcare Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 50. Baxter Healthcare Recent Development
Table 51. Kelun Group Company Details
Table 52. Kelun Group Business Overview
Table 53. Kelun Group Infusion Therapies and Technology Product
Table 54. Kelun Group Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 55. Kelun Group Recent Development
Table 56. Fresenius Company Details
Table 57. Fresenius Business Overview
Table 58. Fresenius Infusion Therapies and Technology Product
Table 59. Fresenius Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 60. Fresenius Recent Development
Table 61. B. Braun Company Details
Table 62. B. Braun Business Overview
Table 63. B. Braun Infusion Therapies and Technology Product
Table 64. B. Braun Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 65. B. Braun Recent Development
Table 66. Ostuka Pharmaceutical Company Details
Table 67. Ostuka Pharmaceutical Business Overview
Table 68. Ostuka Pharmaceutical Infusion Therapies and Technology Product
Table 69. Ostuka Pharmaceutical Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 70. Ostuka Pharmaceutical Recent Development
Table 71. ICU Medical Company Details
Table 72. ICU Medical Business Overview
Table 73. ICU Medical Infusion Therapies and Technology Product
Table 74. ICU Medical Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 75. ICU Medical Recent Development
Table 76. SSY Group Company Details
Table 77. SSY Group Business Overview
Table 78. SSY Group Infusion Therapies and Technology Product
Table 79. SSY Group Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 80. SSY Group Recent Development
Table 81. Shuang Hor Company Details
Table 82. Shuang Hor Business Overview
Table 83. Shuang Hor Infusion Therapies and Technology Product
Table 84. Shuang Hor Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 85. Shuang Hor Recent Development
Table 86. Cisen Pharmaceutical Company Details
Table 87. Cisen Pharmaceutical Business Overview
Table 88. Cisen Pharmaceutical Infusion Therapies and Technology Product
Table 89. Cisen Pharmaceutical Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 90. Cisen Pharmaceutical Recent Development
Table 91. PiSA Farmacéutica Company Details
Table 92. PiSA Farmacéutica Business Overview
Table 93. PiSA Farmacéutica Infusion Therapies and Technology Product
Table 94. PiSA Farmacéutica Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 95. PiSA Farmacéutica Recent Development
Table 96. Huaren Pharmaceutical Company Details
Table 97. Huaren Pharmaceutical Business Overview
Table 98. Huaren Pharmaceutical Infusion Therapies and Technology Product
Table 99. Huaren Pharmaceutical Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 100. Huaren Pharmaceutical Recent Development
Table 101. Chimin Company Details
Table 102. Chimin Business Overview
Table 103. Chimin Infusion Therapies and Technology Product
Table 104. Chimin Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 105. Chimin Recent Development
Table 106. Beximco Pharma Company Details
Table 107. Beximco Pharma Business Overview
Table 108. Beximco Pharma Infusion Therapies and Technology Product
Table 109. Beximco Pharma Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 110. Beximco Pharma Recent Development
Table 111. Albert David Company Details
Table 112. Albert David Business Overview
Table 113. Albert David Infusion Therapies and Technology Product
Table 114. Albert David Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 115. Albert David Recent Development
Table 116. PSI Ltd Company Details
Table 117. PSI Ltd Business Overview
Table 118. PSI Ltd Infusion Therapies and Technology Product
Table 119. PSI Ltd Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 120. PSI Ltd Recent Development
Table 121. Ozon Pharmaceuticals Company Details
Table 122. Ozon Pharmaceuticals Business Overview
Table 123. Ozon Pharmaceuticals Infusion Therapies and Technology Product
Table 124. Ozon Pharmaceuticals Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 125. Ozon Pharmaceuticals Recent Development
Table 126. BML Parenteral Drugs Company Details
Table 127. BML Parenteral Drugs Business Overview
Table 128. BML Parenteral Drugs Infusion Therapies and Technology Product
Table 129. BML Parenteral Drugs Revenue in Infusion Therapies and Technology Business (US$ Million), 2021–2026
Table 130. BML Parenteral Drugs Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Infusion Therapies and Technology Picture
Figure 2. Global Infusion Therapies and Technology Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Infusion Therapies and Technology Market Share by Type: 2025 vs 2032
Figure 4. Large Volume Intravenous Infusion Features
Figure 5. Small Volume Intravenous Infusion Features
Figure 6. Global Infusion Therapies and Technology Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Infusion Therapies and Technology Market Share by Application: 2025 vs 2032
Figure 8. Basic Infusion Case Studies
Figure 9. Therapeutic Infusion Case Studies
Figure 10. Nutritious Infusion Case Studies
Figure 11. Infusion Therapies and Technology Report Years Considered
Figure 12. Global Infusion Therapies and Technology Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Infusion Therapies and Technology Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Infusion Therapies and Technology Market Share by Region: 2025 vs 2032
Figure 15. Global Infusion Therapies and Technology Market Share by Players in 2025
Figure 16. Global Infusion Therapies and Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Infusion Therapies and Technology Revenue in 2025
Figure 18. North America Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Infusion Therapies and Technology Market Share by Country (2021–2032)
Figure 20. United States Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Infusion Therapies and Technology Market Share by Country (2021–2032)
Figure 24. Germany Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Infusion Therapies and Technology Market Share by Region (2021–2032)
Figure 32. China Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Infusion Therapies and Technology Market Share by Country (2021–2032)
Figure 40. Mexico Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Infusion Therapies and Technology Market Share by Country (2021–2032)
Figure 44. Israel Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Infusion Therapies and Technology Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Baxter Healthcare Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 48. Kelun Group Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 49. Fresenius Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 50. B. Braun Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 51. Ostuka Pharmaceutical Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 52. ICU Medical Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 53. SSY Group Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 54. Shuang Hor Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 55. Cisen Pharmaceutical Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 56. PiSA Farmacéutica Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 57. Huaren Pharmaceutical Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 58. Chimin Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 59. Beximco Pharma Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 60. Albert David Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 61. PSI Ltd Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 62. Ozon Pharmaceuticals Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 63. BML Parenteral Drugs Revenue Growth Rate in Infusion Therapies and Technology Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
